KNSA9 quarters
Position history for
DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in KINIKSA PHARMACEUTICALS INTE
Yes. Driehaus Capital Management holds 718,199 shares of KNSA (Kiniksa Pharmaceuticals Inte), worth $45.9M, as of its Q2 2026 13F filing. It increased the position by 106,801 shares (+17.5%) from Q1 2026. Driehaus Capital Management has held KNSA in every 13F on record since Q2 2024, 9 quarterly filings. KNSA is 0.3% of Driehaus Capital Management's reported 13F portfolio.
Current Value
$45.9M
Current Shares
718,199
Total Value Change
+$34.4M
Total Shares Change
+102,363
Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.